1. Klimo P Jr, Schmidt MH. Surgical management of spinal metastases. Oncologist 2004 9:188–96.
2. American Cancer Society. Cancer facts & figures 2007. Atlanta (GA): American Cancer Society; 2007.
3. Sutcliffe P, Connock M, Shyangdan D, Court R, Kandala NB, Clarke A. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression. Health Technol Assess 2013 17:1–274.
4. Weber MH, Burch S, Buckley J, et al. Instability and impending instability of the thoracolumbar spine in patients with spinal metastases: a systematic review. Int J Oncol 2011 38:5–12.
5. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 2010 35:E1221–9.
6. Fourney DR, Frangou EM, Ryken TC, et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 2011 29:3072–7.
7. Campos M, Urrutia J, Zamora T, et al. The Spine Instability Neoplastic Score: an independent reliability and reproducibility analysis. Spine J 2014 14:1466–9.
8. Fisher CG, Versteeg AL, Schouten R, et al. Reliability of the spinal instability neoplastic scale among radiologists: an assessment of instability secondary to spinal metastases. AJR Am J Roentgenol 2014 203:869–74.
10. Arana E, Kovacs FM, Royuela A, et al. Spine Instability Neoplastic Score: agreement across different medical and surgical specialties. Spine J 2016 16:591–9.
11. Quinn RH, Randall RL, Benevenia J, Berven SH, Raskin KA. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners. J Bone Joint Surg Am 2013 95:1887–95.
12. Versteeg AL, van der Velden JM, Verkooijen HM, et al. The effect of introducing the Spinal Instability Neoplastic Score in routine clinical practice for patients with spinal metastases. Oncologist 2016 21:95–101.
13. Versteeg AL, Verlaan JJ, Sahgal A, et al. The Spinal Instability Neoplastic Score: impact on oncologic decision-making. Spine (Phila Pa 1976) 2016 41 Suppl 20:S231–7.
14. Cunha MV, Al-Omair A, Atenafu EG, et al. Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors. Int J Radiat Oncol Biol Phys 2012 84:e343–9.
16. Thibault I, Al-Omair A, Masucci GL, et al. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture. J Neurosurg Spine 2014 21:711–8.
17. Finnigan R, Burmeister B, Barry T, et al. Technique and early clinical outcomes for spinal and paraspinal tumours treated with stereotactic body radiotherapy. J Clin Neurosci 2015 22:1258–63.
18. Lam TC, Uno H, Krishnan M, et al. Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: role of spinal instability and single-fraction radiation therapy. Int J Radiat Oncol Biol Phys 2015 93:373–81.
23. Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 1989 (249):256–64.
24. Harrington KD. Metastatic disease of the spine. J Bone Joint Surg Am 1986 68:1110–5.
25. Kostuik JP, Errico TJ, Gleason TF, Errico CC. Spinal stabilization of vertebral column tumors. Spine (Phila Pa 1976) 1988 13:250–6.
26. Taneichi H, Kaneda K, Takeda N, Abumi K, Satoh S. Risk factors and probability of vertebral body collapse in metastases of the thoracic and lumbar spine. Spine (Phila Pa 1976) 1997 22:239–45.
27. Zadnik PL, Hwang L, Ju DG, et al. Prolonged survival following aggressive treatment for metastatic breast cancer in the spine. Clin Exp Metastasis 2014 31:47–55.
28. Zadnik PL, Goodwin CR, Karami KJ, et al. Outcomes following surgical intervention for impending and gross instability caused by multiple myeloma in the spinal column. J Neurosurg Spine 2015 22:301–9.